The Pain Quality Assessment Scale: Assessment of Pain Quality in Carpal Tunnel Syndrome

Journal of Pain

Volumn 7, Issue 11, 2006, Pages 823-832

  Jensen, Mark P ^a   Gammaitoni, Arnold R ^b   Olaleye, David O ^c   Oleka, Napoleon ^b   Nalamachu, Srinivas R ^d   Galer, Bradley S ^e  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b ENDO PHARMACEUTICALS INC   (United States)

^c SAS INSTITUTE INC   (United States)

^d Mid America Physiatrists   (United States)

^e Topiceutical   (United States)

Author keywords

carpal tunnel syndrome; Neuropathic Pain Scale; Pain assessment; Pain Quality Assessment Scale

Indexed keywords

LIDOCAINE; STEROID;

ADULT; ARTICLE; CARPAL TUNNEL SYNDROME; CLINICAL ARTICLE; COMPARATIVE STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; PAIN; PAIN ASSESSMENT; QUALITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ANESTHETICS, LOCAL; ANTI-INFLAMMATORY AGENTS; CARPAL TUNNEL SYNDROME; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; LIDOCAINE; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PAIN; PAIN MEASUREMENT;

EID: 33750973384     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2006.04.003     Document Type: Article

References (36)

1. Argoff C.E., Galer B.S., Jensen M.P., Oleka N., and Gammaitoni A.R. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: Assessment with the Neuropathic Pain Scale. Curr Med Res Op 20 Suppl 2 (2004) S21-S28
2. Bennett M. The LANSS Pain Scale: The Leeds assessment of neuropathic symptoms and signs. Pain 92 (2001) 147-157
3. Bennett M.I., Smith B.H., Torrance N., and Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: Validation for use in clinical and postal research. J Pain 6 (2005) 149-158
4. Bouhassira D., Attal N., Fermanian J., Alchaar H., Gautron M., Masquelier E., Rostaing S., Lanteri-Minet M., Collin E., Grisart J., and Boureau F. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 108 (2004) 248-257
5. Bouhassira D., Attal N., Alchaar H., Boureau F., Brochet B., Bruxelle J., Cunin G., Fermanian J., Ginies P., Grun-Overdyking A., Jafari-Schluep H., Lantéri-Minet M., Laurent B., Mick G., Serrie A., Valade D., and Vicaut E. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114 (2005) 29-36
6. Boureau F., Doubrere J.F., and Luu M. Study of verbal description in neuropathic pain. Pain 42 (1990) 145-152
7. Carter G.T., Jensen M.P., Galer B.S., Kraft G.H., Crabtree L.D., Beardsley R.M., Abresch R.T., and Bird T.D. Neuropathic pain in Charcot-Marie-Tooth disease. Arch Phys Med Rehabil 79 (1998) 1560-1564
8. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd edition (1988), Lawrence Erlbaum, Hillsdale, NJ
9. Dammers J.W., Veering M.M., and Vermeulen M. Injection with methylprednisolone proximal to the carpal tunnel: Randomized double blind trial. BMJ 319 (1999) 884-886
10. Fishbain D.A., Cutler R.B., Cole B., Lewis J., Smets E., Rosomoff H.L., and Rosomoff R.S. Are patients with chronic low back pain or chronic neck pain fatigued?. Pain Med 5 (2004) 187-195
11. Fishbain D.A., Lewis J., Cole B., Cutler R.B., Smets E., Rosomoff H.L., and Rosomoff R.S. Multidisciplinary pain facility treatment outcome for pain-associated fatigue. Pain Med 6 (2005) 299-304
12. Gammaitoni A.R., Galer B.S., Onawola R., Jensen M.P., and Argoff C.E. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: Results of a pilot 2-week, open-label study using the Neuropathic Pain Scale. Curr Med Res Op 20 Suppl 2 (2004) S13-S19
13. Galer B.S., Gammaitoni A.R., Oleka N., Jensen M.P., and Argoff C.E. Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low back pain. Curr Med Res Op 20 Suppl 2 (2004) S5-S12
14. Galer B.S., Gianas A., and Jensen M.P. Painful diabetic polyneuropathy: Epidemiology, pain description, and quality of life. Diab Res Clin Prac 47 (2000) 123-128
15. Galer B.S., Henderson J., Perander J., and Jensen M.P. Course of symptoms and quality of life measurement in complex regional pain syndrome: A pilot survey. J Pain Symp Manag 20 (2000) 286-292
16. Galer B.S., Jensen M.P., Ma T., Davies P.S., and Rowbotham M.C. The lidocaine patch 5% effectively treats all neuropathic pain qualities: Results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the Neuropathic Pain Scale. Clin J Pain 18 (2002) 297-301
17. Galer B.S., and Jensen M.P. Development and preliminary validation of a pain measure specific to neuropathic pain: The Neuropathic Pain Scale. Neurology 48 (1997) 332-338
18. Gokoglu F., Fndkoglu G., Yorgancoglu Z.R., Okumus M., Ceceli E., and Kocaoglu S. Evaluation of iontophoresis and local corticosteroid injection in the treatment of carpal tunnel syndrome. Am J Phys Med Rehabil 84 (2005) 92-96
19. Jensen M.P. Using pain quality assessment measures for selecting analgesic agents. Clin J Pain 22 Suppl 1 (2005) S9-S13
20. Jensen M.P., Friedman M., Bonzo D., and Richards P. The validity of the Neuropathic Pain Scale for assessing diabetic neuropathic pain in a clinical trial. Clin J Pain 22 (2006) 97-103
21. Jensen M.P., Dworkin R.H., Gammaitoni A.R., Olaleye D.O., Oleka N., and Galer B.S. Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale. J Pain 6 (2005) 98-106
22. Johnansson A., and Bennett G.J. Effect of local methylprednisolone on pain in a nerve injury model: A pilot study. Reg Anesth 22 (1997) 59-65
23. Joshi R. Intraarticular corticosteroid injection for first carpometacarpal osteoarthritis. J Rheumatol 32 (2005) 1305-1306
24. Krause S.J., and Backonja M.M. Development of a neuropathic pain questionnaire. Clin J Pain 19 (2003) 306-314
25. Lewis M., Hay E.M., Paterson S.M., and Croft P. Local steroid injections for tennis elbow: Does the pain get worse before it gets better? -Results from a randomized controlled trial. Clin J Pain 21 (2005) 330-334
26. Lynch M.E., Clark A.J., and Sawynok J. Intravenous adenosine alleviates neuropathic pain: A double blind placebo controlled crossover trial using an enriched enrollment design. Pain 103 (2003) 111-117
27. Melzack R. The short-form McGill Pain Questionnaire. Pain 30 (1987) 191-197
28. Moseley G.L. Graded motor imagery is effective for long-standing complex regional pain syndrome: A randomized controlled trial. Pain 108 (2004) 192-198
29. Nalamachu S., Crockett R.S., and Mathur D. Lidocaine patch 5 for carpal tunnel syndrome: how it compares with injections: a pilot study. J Fam Pract 55 (2006) 209-214
30. Robinson P.P., Boissonade F.M., Loescher A.R., Smith K.G., Yates J.M., Elcock C., Bird E.V., Davies S.L., Smith P.L., and Vora A.R. Peripheral mechanisms for the initiation of pain following trigeminal nerve injury. J Orofac Pain 18 (2004) 287-292
31. Rog D.J., Nurmikko T.J., Friede T., and Young C.A. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 65 (2005) 812-819
32. SAS Institute. SAS/STAT User's Guide, Version 8 (1999), SAS Institute Inc, Cary, NC
33. Schecter A.K., Pariser D.M., Pariser R.J., Ling M.R., Stewart D., and Sadick N.S. Randomized, double-blind, placebo-controlled study evaluating the lidocaine/tetracaine patch for induction of local anesthesia prior to minor dermatologic procedures in geriatric patients. Dermatol Surg 31 (2005) 287-291
34. Tai Q., Kirshblum S., Chen B., Millis S., Johnston M., and DeLisa J.A. Gabapentin in the treatment of neuropathic pain after spinal cord injury: A prospective, randomized, double-blind, crossover trial. J Spinal Cord Med 25 (2002) 100-105
35. Wasner G., Kleinert A., Binder A., Schattschneider J., and Baron R. Postherpetic neuralgia: Topical lidocaine is effective in nociceptor-deprived skin. J Neurol 252 (2005) 677-686
36. Wilkie D.J., Huang H.Y., Reilly N., and Cain K.C. Nociceptive and neuropathic pain in patients with lung cancer. J Pain Symp Manage 22 (2001) 899-910